Tuberculosis
📧 Sign up to get email alerts when something new happens for Tuberculosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: Phase II Clinical Study of Contezolid for the Treatment of Tuberculous Meningitis [Phase 1, Phase 2]
An ongoing Phase I/II clinical trial of contezolid for tuberculous meningitis is currently enrolling by invitation.
-
FDA approval · 2025-02-05FDA Approved: ISONIAZID — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for isoniazid submitted by Chartwell RX, LLC.
-
FDA approval · 2025-02-05FDA Approved: ISONIAZID — Supplemental Application (CMP Pharma, Inc.)
The FDA approved CMP Pharma's supplemental application for isoniazid, authorizing changes to an already approved generic product for tubercu…
-
FDA approval · 2025-02-05FDA Approved: ISONIAZID — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for isoniazid submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2025-02-05FDA Approved: ISONIAZID — Supplemental Application (Marlex Pharmaceuticals, Inc.)
FDA approved a supplemental application for Isoniazid from Marlex Pharmaceuticals, approving changes to the previously approved product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-02-05FDA Approved: ISONIAZID — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for isoniazid (isoniazid) submitted by Chartwell RX, LLC.
-
FDA approval · 2025-02-05FDA Approved: ISONIAZID — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Isoniazid from Teva Pharmaceuticals USA, Inc. (isoniazid), indicating regulatory approval fo…
-
FDA approval · 2025-02-05FDA Approved: ISONIAZID — Supplemental Application (Sandoz Inc)
FDA approves a supplemental application for isoniazid from Sandoz Inc, updating regulatory approval for an existing product.
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Predicting the Future: Incipient Tuberculosis
This clinical trial update reports the completion of a study on predicting incipient tuberculosis.
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB) [Phase 2]
An exploratory Phase 2 study of bedaquiline (TMC207) in Japanese patients with pulmonary multidrug-resistant tuberculosis has completed. The…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB) [Phase 2]
Phase 2 clinical trial evaluating the early bactericidal activity of tedizolid and linezolid against tuberculosis, including multidrug-resis…
-
FDA approval · 2025-01-30FDA Approved: ISONIAZID — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for isoniazid from Chartwell RX, LLC, authorizing changes to the previously approved product.
-
CLINICAL_TRIALS other · 2025-01-30Clinical Trial Update: DRug Use & Infections in ViEtnam: TuBerculosis Control [NA]
A clinical trial update shows a study on drug use and infections for tuberculosis control in Vietnam that is currently recruiting.
-
FDA approval · 2025-01-29FDA Approved: ISONIAZID — Supplemental Application (CMP Pharma, Inc.)
FDA approved CMP Pharma, Inc.'s supplemental application for isoniazid, updating the approved product under an abbreviated new drug applicat…
-
FDA approval · 2025-01-27FDA Approved: ISONIAZID — Supplemental Application (Marlex Pharmaceuticals, Inc.)
FDA approved a supplemental application for isoniazid from Marlex Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Butterfly Pea Flower (Clitoria Ternatea) for Adjuvant TB Treatment [EARLY_Phase 1]
A completed early Phase 1 trial evaluated butterfly pea flower extract (Clitoria ternatea) as an adjuvant therapy for tuberculosis.
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: TB PCR in BAL and EBUS-TBNA
A clinical trial evaluating PCR testing for tuberculosis in bronchoalveolar lavage (BAL) and EBUS-TBNA has completed.
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: Lung Innate Immunity and Microbiome After Tuberculosis Exposure
Ongoing University of Oxford clinical trial investigates how the lung innate immune system and microbiome respond after exposure to tubercul…
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: Drinkers' Intervention to Prevent Tuberculosis (DIPT Study) [NA]
This completed clinical trial (DIPT Study) tested a drinkers' intervention intended to prevent tuberculosis in people with HIV infection. Re…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis
A clinical trial examining patients with mycobacterial infections, tuberculosis, or latent tuberculosis is currently recruiting at IRCCS Azi…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Design of an Integrative Algorithm for Staging Tuberculosis
The document describes the design of an integrative algorithm to stage tuberculosis and notes that recruitment is ongoing.
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Host Blood RNA Signatures for Diagnosis of TB
The University of Stellenbosch-sponsored trial evaluating host blood RNA signatures for diagnosing tuberculosis is currently active but not …
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality [NA]
A clinical trial comparing moderate drinking to abstention is currently recruiting to evaluate effects on all-cause mortality and several ma…
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Phase I Clinical Protocol for Pre-evaluation of the Safety of BCG-PPD in Tuberculosis Patients [Phase 1]
Phase I clinical protocol update assessing the pre-evaluation safety of BCG-PPD in tuberculosis patients; the study is currently active but …
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy Adults [Phase 1]
A Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of the TB drug candidate TBI-223 in healthy adults has completed with …